| Followers | 2421 |
| Posts | 92347 |
| Boards Moderated | 1 |
| Alias Born | 09/12/2003 |
Tuesday, July 07, 2020 3:31:07 PM
The market maker know this is a good stock they want to reloaded restock inventory. They are not ready to let it go yet. It's very frustrated to see them jacking around play game with the stock.
MARK were manipulation trade similar to RVVTF. For months MM keep put up faked ask and won't let it move higher. I was the only one post about the stock and get the DD out. I bought on every dip and hold for months before they let it run from the bottom .25 to near four dollar.
Over the years I make very serious money by acquired good fundamentals stock and hold long for massive gain. Right now I don't even bother to look at the stock nor care to flip for a few cents gain. RVVTF is Super rare, a goldmine, the golden gem. learn to be patience and win big.
MARK were manipulation trade similar to RVVTF. For months MM keep put up faked ask and won't let it move higher. I was the only one post about the stock and get the DD out. I bought on every dip and hold for months before they let it run from the bottom .25 to near four dollar.
Over the years I make very serious money by acquired good fundamentals stock and hold long for massive gain. Right now I don't even bother to look at the stock nor care to flip for a few cents gain. RVVTF is Super rare, a goldmine, the golden gem. learn to be patience and win big.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM

